nodes	percent_of_prediction	percent_of_DWPC	metapath
Tranexamic Acid—PLG—Dissolution of Fibrin Clot—ANXA2—kidney cancer	0.0292	0.138	CbGpPWpGaD
Tranexamic Acid—PLG—nephron tubule—kidney cancer	0.0215	0.178	CbGeAlD
Tranexamic Acid—PLG—renal system—kidney cancer	0.0195	0.162	CbGeAlD
Tranexamic Acid—PLG—kidney—kidney cancer	0.0189	0.156	CbGeAlD
Tranexamic Acid—PLG—cortex of kidney—kidney cancer	0.0184	0.152	CbGeAlD
Tranexamic Acid—PLG—gonad—kidney cancer	0.0175	0.145	CbGeAlD
Tranexamic Acid—PLG—Regulation of IGF Activity by IGFBP—IGF2—kidney cancer	0.00822	0.039	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—GRB7—kidney cancer	0.00718	0.034	CbGpPWpGaD
Tranexamic Acid—SLC15A2—nephron tubule—kidney cancer	0.00687	0.0569	CbGeAlD
Tranexamic Acid—SLC15A2—renal system—kidney cancer	0.00624	0.0517	CbGeAlD
Tranexamic Acid—SLC15A2—kidney—kidney cancer	0.00603	0.05	CbGeAlD
Tranexamic Acid—SLC15A2—cortex of kidney—kidney cancer	0.00588	0.0487	CbGeAlD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—APAF1—kidney cancer	0.0057	0.027	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—SCARB1—kidney cancer	0.00567	0.0269	CbGpPWpGaD
Tranexamic Acid—PLG—Orphan transporters—ANXA2—kidney cancer	0.00553	0.0262	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—PAK1—kidney cancer	0.00502	0.0238	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—SCARB1—kidney cancer	0.00461	0.0219	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—SOD2—kidney cancer	0.00383	0.0182	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—SCARB1—kidney cancer	0.00367	0.0174	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—CTSB—kidney cancer	0.00365	0.0173	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—CTSD—kidney cancer	0.00363	0.0172	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—PTGS1—kidney cancer	0.00363	0.0172	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—SOD2—kidney cancer	0.00312	0.0148	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Amino acid and oligopeptide SLC transporters—SLC5A5—kidney cancer	0.00304	0.0144	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—IGF2—kidney cancer	0.00282	0.0134	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—IGF2—kidney cancer	0.00269	0.0127	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—GRB7—kidney cancer	0.00255	0.0121	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—SOD2—kidney cancer	0.00248	0.0117	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—ITPR2—kidney cancer	0.00237	0.0113	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—RYR1—kidney cancer	0.00235	0.0111	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—RELA—kidney cancer	0.00225	0.0107	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—BMP7—kidney cancer	0.00223	0.0106	CbGpPWpGaD
Tranexamic Acid—PLG—Vitamin B12 Metabolism—RELA—kidney cancer	0.00221	0.0105	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—L1CAM—kidney cancer	0.00206	0.00975	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—ITPR2—kidney cancer	0.00203	0.00964	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—EIF5B—kidney cancer	0.00198	0.00941	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—RELA—kidney cancer	0.0018	0.00854	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC5A5—kidney cancer	0.00179	0.00848	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—CUL7—kidney cancer	0.00177	0.00839	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—HSPA9—kidney cancer	0.00169	0.008	CbGpPWpGaD
Tranexamic Acid—PLG—Degradation of the extracellular matrix—CDH1—kidney cancer	0.00167	0.00792	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—MAPK3—kidney cancer	0.00163	0.00772	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—IL2—kidney cancer	0.00162	0.00769	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—ANXA2—kidney cancer	0.00156	0.00739	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—MAPK1—kidney cancer	0.00155	0.00735	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—CTSB—kidney cancer	0.00153	0.00725	CbGpPWpGaD
Tranexamic Acid—PLG—Extracellular matrix organization—CTSD—kidney cancer	0.00152	0.00722	CbGpPWpGaD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.00152	0.00719	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—RELA—kidney cancer	0.00143	0.00678	CbGpPWpGaD
Tranexamic Acid—PLG—Selenium Micronutrient Network—PTGS2—kidney cancer	0.00139	0.00659	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—MUC4—kidney cancer	0.00138	0.00652	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.00135	0.0064	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.00135	0.0064	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.00135	0.0064	CbGpPWpGaD
Tranexamic Acid—PLG—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—kidney cancer	0.00134	0.00638	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—RYR1—kidney cancer	0.00134	0.00636	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—ST3GAL2—kidney cancer	0.00131	0.0062	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—KCNMA1—kidney cancer	0.00129	0.00612	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—EEF2—kidney cancer	0.00128	0.00606	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—IGF2—kidney cancer	0.00125	0.00593	CbGpPWpGaD
Tranexamic Acid—PLG—Platelet degranulation—VEGFA—kidney cancer	0.00118	0.0056	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—TSC2—kidney cancer	0.00116	0.0055	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—GRB7—kidney cancer	0.00113	0.00534	CbGpPWpGaD
Tranexamic Acid—PLG—Response to elevated platelet cytosolic Ca2+—VEGFA—kidney cancer	0.00113	0.00534	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—ITPR2—kidney cancer	0.00105	0.00497	CbGpPWpGaD
Tranexamic Acid—PLG—Folate Metabolism—TP53—kidney cancer	0.00104	0.00494	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—PIK3CA—kidney cancer	0.00104	0.00493	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—KIT—kidney cancer	0.00102	0.00486	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—OR4C13—kidney cancer	0.00101	0.00477	CbGpPWpGaD
Tranexamic Acid—PLG—p75(NTR)-mediated signaling—TP53—kidney cancer	0.00101	0.00477	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—MME—kidney cancer	0.00098	0.00465	CbGpPWpGaD
Tranexamic Acid—Dyspepsia—Erlotinib—kidney cancer	0.000955	0.00143	CcSEcCtD
Tranexamic Acid—Arrhythmia—Gemcitabine—kidney cancer	0.000948	0.00142	CcSEcCtD
Tranexamic Acid—Headache—Temsirolimus—kidney cancer	0.000947	0.00142	CcSEcCtD
Tranexamic Acid—Musculoskeletal pain—Doxorubicin—kidney cancer	0.000947	0.00142	CcSEcCtD
Tranexamic Acid—Dizziness—Pazopanib—kidney cancer	0.000942	0.00141	CcSEcCtD
Tranexamic Acid—Back pain—Vincristine—kidney cancer	0.000942	0.00141	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Erlotinib—kidney cancer	0.000937	0.0014	CcSEcCtD
Tranexamic Acid—Pulmonary embolism—Doxorubicin—kidney cancer	0.000936	0.0014	CcSEcCtD
Tranexamic Acid—Ventricular tachycardia—Doxorubicin—kidney cancer	0.000936	0.0014	CcSEcCtD
Tranexamic Acid—Fatigue—Erlotinib—kidney cancer	0.000935	0.0014	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Vinblastine—kidney cancer	0.00093	0.00139	CcSEcCtD
Tranexamic Acid—Sinusitis—Paclitaxel—kidney cancer	0.000928	0.00139	CcSEcCtD
Tranexamic Acid—Myalgia—Dactinomycin—kidney cancer	0.000928	0.00139	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Everolimus—kidney cancer	0.000927	0.00139	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Vinblastine—kidney cancer	0.000923	0.00138	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Sunitinib—kidney cancer	0.000921	0.00138	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Everolimus—kidney cancer	0.00092	0.00138	CcSEcCtD
Tranexamic Acid—Discomfort—Dactinomycin—kidney cancer	0.000916	0.00137	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—RPL14—kidney cancer	0.000911	0.00432	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—HSPD1—kidney cancer	0.000911	0.00432	CbGpPWpGaD
Tranexamic Acid—Vomiting—Pazopanib—kidney cancer	0.000906	0.00135	CcSEcCtD
Tranexamic Acid—Anaemia—Vincristine—kidney cancer	0.0009	0.00135	CcSEcCtD
Tranexamic Acid—Nausea—Temsirolimus—kidney cancer	0.000898	0.00134	CcSEcCtD
Tranexamic Acid—Back pain—Gemcitabine—kidney cancer	0.000893	0.00134	CcSEcCtD
Tranexamic Acid—Haemoglobin—Paclitaxel—kidney cancer	0.000893	0.00134	CcSEcCtD
Tranexamic Acid—Abdominal pain—Vinblastine—kidney cancer	0.000892	0.00134	CcSEcCtD
Tranexamic Acid—Headache—Pazopanib—kidney cancer	0.000892	0.00133	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000889	0.00133	CcSEcCtD
Tranexamic Acid—Abdominal pain—Everolimus—kidney cancer	0.000889	0.00133	CcSEcCtD
Tranexamic Acid—Haemorrhage—Paclitaxel—kidney cancer	0.000888	0.00133	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Erlotinib—kidney cancer	0.000887	0.00133	CcSEcCtD
Tranexamic Acid—Angina pectoris—Capecitabine—kidney cancer	0.000887	0.00133	CcSEcCtD
Tranexamic Acid—Abdominal discomfort—Capecitabine—kidney cancer	0.000873	0.00131	CcSEcCtD
Tranexamic Acid—Dyspnoea—Sorafenib—kidney cancer	0.00087	0.0013	CcSEcCtD
Tranexamic Acid—Dyspepsia—Sorafenib—kidney cancer	0.000859	0.00129	CcSEcCtD
Tranexamic Acid—Abdominal pain—Erlotinib—kidney cancer	0.000858	0.00128	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Gemcitabine—kidney cancer	0.000857	0.00128	CcSEcCtD
Tranexamic Acid—Visual impairment—Paclitaxel—kidney cancer	0.000856	0.00128	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000856	0.00128	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—LATS1—kidney cancer	0.000855	0.00406	CbGpPWpGaD
Tranexamic Acid—Anaemia—Gemcitabine—kidney cancer	0.000853	0.00128	CcSEcCtD
Tranexamic Acid—Nausea—Pazopanib—kidney cancer	0.000846	0.00127	CcSEcCtD
Tranexamic Acid—Convulsion—Vincristine—kidney cancer	0.000843	0.00126	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Sorafenib—kidney cancer	0.000843	0.00126	CcSEcCtD
Tranexamic Acid—Fatigue—Sorafenib—kidney cancer	0.000842	0.00126	CcSEcCtD
Tranexamic Acid—Dyspnoea—Sunitinib—kidney cancer	0.000837	0.00125	CcSEcCtD
Tranexamic Acid—Malaise—Gemcitabine—kidney cancer	0.000833	0.00125	CcSEcCtD
Tranexamic Acid—Pulmonary oedema—Doxorubicin—kidney cancer	0.000833	0.00125	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Vinblastine—kidney cancer	0.000832	0.00124	CcSEcCtD
Tranexamic Acid—Eye disorder—Paclitaxel—kidney cancer	0.00083	0.00124	CcSEcCtD
Tranexamic Acid—Myalgia—Vincristine—kidney cancer	0.000829	0.00124	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Everolimus—kidney cancer	0.000828	0.00124	CcSEcCtD
Tranexamic Acid—Dyspepsia—Sunitinib—kidney cancer	0.000827	0.00124	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—KDR—kidney cancer	0.000826	0.00391	CbGpPWpGaD
Tranexamic Acid—Cardiac disorder—Paclitaxel—kidney cancer	0.000824	0.00123	CcSEcCtD
Tranexamic Acid—Flushing—Paclitaxel—kidney cancer	0.000824	0.00123	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Sunitinib—kidney cancer	0.000811	0.00121	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.00081	0.00121	CcSEcCtD
Tranexamic Acid—Asthenia—Vinblastine—kidney cancer	0.00081	0.00121	CcSEcCtD
Tranexamic Acid—Fatigue—Sunitinib—kidney cancer	0.00081	0.00121	CcSEcCtD
Tranexamic Acid—Asthenia—Everolimus—kidney cancer	0.000807	0.00121	CcSEcCtD
Tranexamic Acid—Angiopathy—Paclitaxel—kidney cancer	0.000806	0.00121	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—RAF1—kidney cancer	0.000804	0.00381	CbGpPWpGaD
Tranexamic Acid—Immune system disorder—Paclitaxel—kidney cancer	0.000802	0.0012	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Paclitaxel—kidney cancer	0.0008	0.0012	CcSEcCtD
Tranexamic Acid—Acute coronary syndrome—Capecitabine—kidney cancer	0.0008	0.0012	CcSEcCtD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000799	0.00379	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal pain—Sorafenib—kidney cancer	0.000798	0.00119	CcSEcCtD
Tranexamic Acid—Renal failure—Capecitabine—kidney cancer	0.000798	0.00119	CcSEcCtD
Tranexamic Acid—Myocardial infarction—Capecitabine—kidney cancer	0.000796	0.00119	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—ERBB2—kidney cancer	0.000795	0.00377	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Vincristine—kidney cancer	0.000794	0.00119	CcSEcCtD
Tranexamic Acid—Arrhythmia—Paclitaxel—kidney cancer	0.000793	0.00119	CcSEcCtD
Tranexamic Acid—Arthralgia—Gemcitabine—kidney cancer	0.000786	0.00118	CcSEcCtD
Tranexamic Acid—Chest pain—Gemcitabine—kidney cancer	0.000786	0.00118	CcSEcCtD
Tranexamic Acid—Myalgia—Gemcitabine—kidney cancer	0.000786	0.00118	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—MTOR—kidney cancer	0.000785	0.00372	CbGpPWpGaD
Tranexamic Acid—Nervous system disorder—Vincristine—kidney cancer	0.000779	0.00117	CcSEcCtD
Tranexamic Acid—Asthenia—Erlotinib—kidney cancer	0.000778	0.00116	CcSEcCtD
Tranexamic Acid—Discomfort—Gemcitabine—kidney cancer	0.000777	0.00116	CcSEcCtD
Tranexamic Acid—Diarrhoea—Vinblastine—kidney cancer	0.000772	0.00116	CcSEcCtD
Tranexamic Acid—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000772	0.00366	CbGpPWpGaD
Tranexamic Acid—Abdominal pain—Sorafenib—kidney cancer	0.000772	0.00115	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.00077	0.00365	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.00077	0.00365	CbGpPWpGaD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.00077	0.00365	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Everolimus—kidney cancer	0.000769	0.00115	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—IFNA1—kidney cancer	0.000769	0.00365	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal pain—Sunitinib—kidney cancer	0.000768	0.00115	CcSEcCtD
Tranexamic Acid—Fatigue—Dactinomycin—kidney cancer	0.000767	0.00115	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Gemcitabine—kidney cancer	0.000754	0.00113	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—ACHE—kidney cancer	0.000752	0.00356	CbGpPWpGaD
Tranexamic Acid—Back pain—Paclitaxel—kidney cancer	0.000748	0.00112	CcSEcCtD
Tranexamic Acid—Dizziness—Vinblastine—kidney cancer	0.000746	0.00112	CcSEcCtD
Tranexamic Acid—Dizziness—Everolimus—kidney cancer	0.000744	0.00111	CcSEcCtD
Tranexamic Acid—Muscle spasms—Paclitaxel—kidney cancer	0.000743	0.00111	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—EIF4EBP1—kidney cancer	0.000743	0.00352	CbGpPWpGaD
Tranexamic Acid—Abdominal pain—Sunitinib—kidney cancer	0.000742	0.00111	CcSEcCtD
Tranexamic Acid—Diarrhoea—Erlotinib—kidney cancer	0.000742	0.00111	CcSEcCtD
Tranexamic Acid—Hypotension—Vincristine—kidney cancer	0.000742	0.00111	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Gemcitabine—kidney cancer	0.000739	0.00111	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—CDKN1B—kidney cancer	0.000736	0.00349	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Dactinomycin—kidney cancer	0.000733	0.0011	CcSEcCtD
Tranexamic Acid—Haemoglobin—Capecitabine—kidney cancer	0.000733	0.0011	CcSEcCtD
Tranexamic Acid—Haemorrhage—Capecitabine—kidney cancer	0.000729	0.00109	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—AMER1—kidney cancer	0.000727	0.00345	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000727	0.00109	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000724	0.00108	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Sorafenib—kidney cancer	0.000719	0.00108	CcSEcCtD
Tranexamic Acid—Vomiting—Vinblastine—kidney cancer	0.000718	0.00107	CcSEcCtD
Tranexamic Acid—Dizziness—Erlotinib—kidney cancer	0.000717	0.00107	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Paclitaxel—kidney cancer	0.000717	0.00107	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—IFNA2—kidney cancer	0.000716	0.00339	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—PAX6—kidney cancer	0.000715	0.00339	CbGpPWpGaD
Tranexamic Acid—Vomiting—Everolimus—kidney cancer	0.000715	0.00107	CcSEcCtD
Tranexamic Acid—Anaemia—Paclitaxel—kidney cancer	0.000715	0.00107	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000712	0.00337	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—CTSD—kidney cancer	0.000711	0.00337	CbGpPWpGaD
Tranexamic Acid—Headache—Vinblastine—kidney cancer	0.000707	0.00106	CcSEcCtD
Tranexamic Acid—Headache—Everolimus—kidney cancer	0.000704	0.00105	CcSEcCtD
Tranexamic Acid—Hypotension—Gemcitabine—kidney cancer	0.000704	0.00105	CcSEcCtD
Tranexamic Acid—Abdominal pain—Dactinomycin—kidney cancer	0.000703	0.00105	CcSEcCtD
Tranexamic Acid—Visual impairment—Capecitabine—kidney cancer	0.000702	0.00105	CcSEcCtD
Tranexamic Acid—Anaphylactoid reaction—Doxorubicin—kidney cancer	0.000702	0.00105	CcSEcCtD
Tranexamic Acid—Asthenia—Sorafenib—kidney cancer	0.0007	0.00105	CcSEcCtD
Tranexamic Acid—PLG—Extracellular matrix organization—CDH1—kidney cancer	0.0007	0.00332	CbGpPWpGaD
Tranexamic Acid—Malaise—Paclitaxel—kidney cancer	0.000697	0.00104	CcSEcCtD
Tranexamic Acid—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000693	0.00104	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Sunitinib—kidney cancer	0.000692	0.00104	CcSEcCtD
Tranexamic Acid—Vomiting—Erlotinib—kidney cancer	0.00069	0.00103	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—RAF1—kidney cancer	0.000688	0.00326	CbGpPWpGaD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000687	0.00326	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000687	0.00103	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Vincristine—kidney cancer	0.000686	0.00103	CcSEcCtD
Tranexamic Acid—Fatigue—Vincristine—kidney cancer	0.000685	0.00102	CcSEcCtD
Tranexamic Acid—Eye disorder—Capecitabine—kidney cancer	0.000681	0.00102	CcSEcCtD
Tranexamic Acid—Headache—Erlotinib—kidney cancer	0.00068	0.00102	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Paclitaxel—kidney cancer	0.00068	0.00102	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—PTEN—kidney cancer	0.000678	0.00321	CbGpPWpGaD
Tranexamic Acid—Flushing—Capecitabine—kidney cancer	0.000676	0.00101	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Capecitabine—kidney cancer	0.000676	0.00101	CcSEcCtD
Tranexamic Acid—Asthenia—Sunitinib—kidney cancer	0.000674	0.00101	CcSEcCtD
Tranexamic Acid—Dyspnoea—Gemcitabine—kidney cancer	0.000672	0.00101	CcSEcCtD
Tranexamic Acid—Nausea—Vinblastine—kidney cancer	0.000671	0.001	CcSEcCtD
Tranexamic Acid—Convulsion—Paclitaxel—kidney cancer	0.00067	0.001	CcSEcCtD
Tranexamic Acid—Migraine—Doxorubicin—kidney cancer	0.000668	0.001	CcSEcCtD
Tranexamic Acid—Nausea—Everolimus—kidney cancer	0.000668	0.000999	CcSEcCtD
Tranexamic Acid—Diarrhoea—Sorafenib—kidney cancer	0.000668	0.000999	CcSEcCtD
Tranexamic Acid—Angiopathy—Capecitabine—kidney cancer	0.000661	0.000989	CcSEcCtD
Tranexamic Acid—Immune system disorder—Capecitabine—kidney cancer	0.000658	0.000985	CcSEcCtD
Tranexamic Acid—Myalgia—Paclitaxel—kidney cancer	0.000658	0.000985	CcSEcCtD
Tranexamic Acid—Chest pain—Paclitaxel—kidney cancer	0.000658	0.000985	CcSEcCtD
Tranexamic Acid—Arthralgia—Paclitaxel—kidney cancer	0.000658	0.000985	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Capecitabine—kidney cancer	0.000657	0.000983	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Dactinomycin—kidney cancer	0.000655	0.00098	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—BCHE—kidney cancer	0.000655	0.0031	CbGpPWpGaD
Tranexamic Acid—Arrhythmia—Capecitabine—kidney cancer	0.000651	0.000974	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000651	0.000974	CcSEcCtD
Tranexamic Acid—Discomfort—Paclitaxel—kidney cancer	0.00065	0.000973	CcSEcCtD
Tranexamic Acid—Fatigue—Gemcitabine—kidney cancer	0.00065	0.000972	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Vincristine—kidney cancer	0.00065	0.000972	CcSEcCtD
Tranexamic Acid—Dizziness—Sorafenib—kidney cancer	0.000645	0.000966	CcSEcCtD
Tranexamic Acid—Nausea—Erlotinib—kidney cancer	0.000644	0.000964	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—IGF2—kidney cancer	0.000644	0.00306	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Sunitinib—kidney cancer	0.000643	0.000962	CcSEcCtD
Tranexamic Acid—Asthenia—Dactinomycin—kidney cancer	0.000638	0.000955	CcSEcCtD
Tranexamic Acid—Anaphylactic shock—Paclitaxel—kidney cancer	0.000631	0.000944	CcSEcCtD
Tranexamic Acid—Abdominal pain—Vincristine—kidney cancer	0.000628	0.00094	CcSEcCtD
Tranexamic Acid—Dizziness—Sunitinib—kidney cancer	0.000621	0.000929	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Gemcitabine—kidney cancer	0.000621	0.000929	CcSEcCtD
Tranexamic Acid—Vomiting—Sorafenib—kidney cancer	0.000621	0.000929	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Paclitaxel—kidney cancer	0.000619	0.000926	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—IL2—kidney cancer	0.000617	0.00293	CbGpPWpGaD
Tranexamic Acid—Back pain—Capecitabine—kidney cancer	0.000614	0.000918	CcSEcCtD
Tranexamic Acid—Headache—Sorafenib—kidney cancer	0.000611	0.000915	CcSEcCtD
Tranexamic Acid—Muscle spasms—Capecitabine—kidney cancer	0.00061	0.000913	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—GPC3—kidney cancer	0.00061	0.00289	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CER1—kidney cancer	0.00061	0.00289	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Dactinomycin—kidney cancer	0.000608	0.00091	CcSEcCtD
Tranexamic Acid—Vomiting—Sunitinib—kidney cancer	0.000597	0.000894	CcSEcCtD
Tranexamic Acid—Hypotension—Paclitaxel—kidney cancer	0.00059	0.000882	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Capecitabine—kidney cancer	0.000589	0.000881	CcSEcCtD
Tranexamic Acid—Headache—Sunitinib—kidney cancer	0.000588	0.00088	CcSEcCtD
Tranexamic Acid—Anaemia—Capecitabine—kidney cancer	0.000586	0.000877	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Vincristine—kidney cancer	0.000585	0.000876	CcSEcCtD
Tranexamic Acid—Nausea—Sorafenib—kidney cancer	0.00058	0.000868	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—MAPK3—kidney cancer	0.000579	0.00275	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000575	0.00086	CcSEcCtD
Tranexamic Acid—Malaise—Capecitabine—kidney cancer	0.000572	0.000856	CcSEcCtD
Tranexamic Acid—Angina pectoris—Doxorubicin—kidney cancer	0.000572	0.000855	CcSEcCtD
Tranexamic Acid—Asthenia—Vincristine—kidney cancer	0.00057	0.000853	CcSEcCtD
Tranexamic Acid—Vomiting—Dactinomycin—kidney cancer	0.000565	0.000846	CcSEcCtD
Tranexamic Acid—Dyspnoea—Paclitaxel—kidney cancer	0.000563	0.000842	CcSEcCtD
Tranexamic Acid—Nausea—Sunitinib—kidney cancer	0.000558	0.000835	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Capecitabine—kidney cancer	0.000558	0.000834	CcSEcCtD
Tranexamic Acid—Dyspepsia—Paclitaxel—kidney cancer	0.000555	0.000831	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—MAPK1—kidney cancer	0.000551	0.00261	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000545	0.000815	CcSEcCtD
Tranexamic Acid—Fatigue—Paclitaxel—kidney cancer	0.000544	0.000814	CcSEcCtD
Tranexamic Acid—Diarrhoea—Vincristine—kidney cancer	0.000544	0.000813	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000543	0.00257	CbGpPWpGaD
Tranexamic Acid—Asthenia—Gemcitabine—kidney cancer	0.000541	0.000809	CcSEcCtD
Tranexamic Acid—Chest pain—Capecitabine—kidney cancer	0.00054	0.000808	CcSEcCtD
Tranexamic Acid—Arthralgia—Capecitabine—kidney cancer	0.00054	0.000808	CcSEcCtD
Tranexamic Acid—Myalgia—Capecitabine—kidney cancer	0.00054	0.000808	CcSEcCtD
Tranexamic Acid—Discomfort—Capecitabine—kidney cancer	0.000534	0.000799	CcSEcCtD
Tranexamic Acid—Nausea—Dactinomycin—kidney cancer	0.000528	0.00079	CcSEcCtD
Tranexamic Acid—Dizziness—Vincristine—kidney cancer	0.000525	0.000786	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—VEGFA—kidney cancer	0.000524	0.00249	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling by PDGF—KRAS—kidney cancer	0.000521	0.00247	CbGpPWpGaD
Tranexamic Acid—Feeling abnormal—Paclitaxel—kidney cancer	0.00052	0.000778	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—SFRP2—kidney cancer	0.000518	0.00246	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000516	0.000772	CcSEcCtD
Tranexamic Acid—Diarrhoea—Gemcitabine—kidney cancer	0.000516	0.000772	CcSEcCtD
Tranexamic Acid—Renal failure—Doxorubicin—kidney cancer	0.000514	0.00077	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Capecitabine—kidney cancer	0.000508	0.00076	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—IGF2—kidney cancer	0.000507	0.0024	CbGpPWpGaD
Tranexamic Acid—Vomiting—Vincristine—kidney cancer	0.000505	0.000756	CcSEcCtD
Tranexamic Acid—Abdominal pain—Paclitaxel—kidney cancer	0.000499	0.000746	CcSEcCtD
Tranexamic Acid—Headache—Vincristine—kidney cancer	0.000498	0.000745	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—MAPK3—kidney cancer	0.000496	0.00235	CbGpPWpGaD
Tranexamic Acid—Sinusitis—Doxorubicin—kidney cancer	0.000491	0.000735	CcSEcCtD
Tranexamic Acid—Hypotension—Capecitabine—kidney cancer	0.000484	0.000724	CcSEcCtD
Tranexamic Acid—Vomiting—Gemcitabine—kidney cancer	0.000479	0.000717	CcSEcCtD
Tranexamic Acid—PLG—Signaling by PDGF—PIK3CA—kidney cancer	0.000478	0.00227	CbGpPWpGaD
Tranexamic Acid—Haemoglobin—Doxorubicin—kidney cancer	0.000472	0.000707	CcSEcCtD
Tranexamic Acid—Headache—Gemcitabine—kidney cancer	0.000472	0.000706	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—MAPK1—kidney cancer	0.000472	0.00224	CbGpPWpGaD
Tranexamic Acid—Nausea—Vincristine—kidney cancer	0.000472	0.000706	CcSEcCtD
Tranexamic Acid—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000472	0.000706	CcSEcCtD
Tranexamic Acid—Haemorrhage—Doxorubicin—kidney cancer	0.00047	0.000703	CcSEcCtD
Tranexamic Acid—Hypersensitivity—Paclitaxel—kidney cancer	0.000465	0.000696	CcSEcCtD
Tranexamic Acid—Dyspnoea—Capecitabine—kidney cancer	0.000462	0.000691	CcSEcCtD
Tranexamic Acid—Dyspepsia—Capecitabine—kidney cancer	0.000456	0.000682	CcSEcCtD
Tranexamic Acid—Visual impairment—Doxorubicin—kidney cancer	0.000453	0.000677	CcSEcCtD
Tranexamic Acid—Asthenia—Paclitaxel—kidney cancer	0.000453	0.000677	CcSEcCtD
Tranexamic Acid—Nausea—Gemcitabine—kidney cancer	0.000448	0.00067	CcSEcCtD
Tranexamic Acid—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000447	0.000669	CcSEcCtD
Tranexamic Acid—Fatigue—Capecitabine—kidney cancer	0.000446	0.000668	CcSEcCtD
Tranexamic Acid—Eye disorder—Doxorubicin—kidney cancer	0.000439	0.000657	CcSEcCtD
Tranexamic Acid—Flushing—Doxorubicin—kidney cancer	0.000436	0.000652	CcSEcCtD
Tranexamic Acid—Cardiac disorder—Doxorubicin—kidney cancer	0.000436	0.000652	CcSEcCtD
Tranexamic Acid—Diarrhoea—Paclitaxel—kidney cancer	0.000432	0.000646	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Capecitabine—kidney cancer	0.000427	0.000638	CcSEcCtD
Tranexamic Acid—Angiopathy—Doxorubicin—kidney cancer	0.000426	0.000638	CcSEcCtD
Tranexamic Acid—Immune system disorder—Doxorubicin—kidney cancer	0.000424	0.000635	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Capecitabine—kidney cancer	0.000423	0.000634	CcSEcCtD
Tranexamic Acid—Mediastinal disorder—Doxorubicin—kidney cancer	0.000423	0.000634	CcSEcCtD
Tranexamic Acid—Arrhythmia—Doxorubicin—kidney cancer	0.00042	0.000628	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—AKAP13—kidney cancer	0.000418	0.00198	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CASP2—kidney cancer	0.000418	0.00198	CbGpPWpGaD
Tranexamic Acid—Dizziness—Paclitaxel—kidney cancer	0.000417	0.000624	CcSEcCtD
Tranexamic Acid—PLG—Platelet activation, signaling and aggregation—PIK3CA—kidney cancer	0.00041	0.00194	CbGpPWpGaD
Tranexamic Acid—Abdominal pain—Capecitabine—kidney cancer	0.000409	0.000612	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000406	0.00193	CbGpPWpGaD
Tranexamic Acid—Vomiting—Paclitaxel—kidney cancer	0.000401	0.0006	CcSEcCtD
Tranexamic Acid—Back pain—Doxorubicin—kidney cancer	0.000396	0.000592	CcSEcCtD
Tranexamic Acid—Headache—Paclitaxel—kidney cancer	0.000395	0.000591	CcSEcCtD
Tranexamic Acid—Muscle spasms—Doxorubicin—kidney cancer	0.000393	0.000588	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000392	0.00186	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—GRB7—kidney cancer	0.000382	0.00181	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Capecitabine—kidney cancer	0.000382	0.000571	CcSEcCtD
Tranexamic Acid—Ill-defined disorder—Doxorubicin—kidney cancer	0.000379	0.000568	CcSEcCtD
Tranexamic Acid—Anaemia—Doxorubicin—kidney cancer	0.000378	0.000566	CcSEcCtD
Tranexamic Acid—Nausea—Paclitaxel—kidney cancer	0.000375	0.000561	CcSEcCtD
Tranexamic Acid—Asthenia—Capecitabine—kidney cancer	0.000372	0.000556	CcSEcCtD
Tranexamic Acid—Malaise—Doxorubicin—kidney cancer	0.000369	0.000552	CcSEcCtD
Tranexamic Acid—Loss of consciousness—Doxorubicin—kidney cancer	0.000359	0.000538	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—ITPR2—kidney cancer	0.000355	0.00168	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—RAF1—kidney cancer	0.000355	0.00168	CbGpPWpGaD
Tranexamic Acid—Convulsion—Doxorubicin—kidney cancer	0.000354	0.00053	CcSEcCtD
Tranexamic Acid—Diarrhoea—Capecitabine—kidney cancer	0.000354	0.00053	CcSEcCtD
Tranexamic Acid—Chest pain—Doxorubicin—kidney cancer	0.000348	0.000521	CcSEcCtD
Tranexamic Acid—Myalgia—Doxorubicin—kidney cancer	0.000348	0.000521	CcSEcCtD
Tranexamic Acid—Arthralgia—Doxorubicin—kidney cancer	0.000348	0.000521	CcSEcCtD
Tranexamic Acid—Discomfort—Doxorubicin—kidney cancer	0.000344	0.000515	CcSEcCtD
Tranexamic Acid—Dizziness—Capecitabine—kidney cancer	0.000342	0.000512	CcSEcCtD
Tranexamic Acid—PLG—Metabolism of proteins—POMC—kidney cancer	0.000338	0.0016	CbGpPWpGaD
Tranexamic Acid—Anaphylactic shock—Doxorubicin—kidney cancer	0.000334	0.000499	CcSEcCtD
Tranexamic Acid—Vomiting—Capecitabine—kidney cancer	0.000329	0.000493	CcSEcCtD
Tranexamic Acid—Nervous system disorder—Doxorubicin—kidney cancer	0.000327	0.00049	CcSEcCtD
Tranexamic Acid—Headache—Capecitabine—kidney cancer	0.000324	0.000485	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—CTNNA1—kidney cancer	0.000322	0.00153	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—EIF4EBP1—kidney cancer	0.00032	0.00152	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HSPB1—kidney cancer	0.00032	0.00152	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—IL2—kidney cancer	0.000318	0.00151	CbGpPWpGaD
Tranexamic Acid—Hypotension—Doxorubicin—kidney cancer	0.000312	0.000467	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.00031	0.00147	CbGpPWpGaD
Tranexamic Acid—Nausea—Capecitabine—kidney cancer	0.000308	0.00046	CcSEcCtD
Tranexamic Acid—PLG—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000307	0.00146	CbGpPWpGaD
Tranexamic Acid—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000304	0.000455	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—PSMD7—kidney cancer	0.000298	0.00141	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TSC1—kidney cancer	0.000298	0.00141	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ANXA1—kidney cancer	0.000298	0.00141	CbGpPWpGaD
Tranexamic Acid—Dyspnoea—Doxorubicin—kidney cancer	0.000298	0.000445	CcSEcCtD
Tranexamic Acid—Dyspepsia—Doxorubicin—kidney cancer	0.000294	0.00044	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—FLT1—kidney cancer	0.000288	0.00137	CbGpPWpGaD
Tranexamic Acid—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000288	0.000431	CcSEcCtD
Tranexamic Acid—Fatigue—Doxorubicin—kidney cancer	0.000288	0.000431	CcSEcCtD
Tranexamic Acid—Feeling abnormal—Doxorubicin—kidney cancer	0.000275	0.000412	CcSEcCtD
Tranexamic Acid—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000273	0.000408	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—VEGFA—kidney cancer	0.00027	0.00128	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PAK1—kidney cancer	0.000267	0.00127	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—JUNB—kidney cancer	0.000267	0.00127	CbGpPWpGaD
Tranexamic Acid—Abdominal pain—Doxorubicin—kidney cancer	0.000264	0.000395	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—MAPK3—kidney cancer	0.000256	0.00121	CbGpPWpGaD
Tranexamic Acid—Hypersensitivity—Doxorubicin—kidney cancer	0.000246	0.000368	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—MAPK1—kidney cancer	0.000243	0.00115	CbGpPWpGaD
Tranexamic Acid—PLG—Metabolism of proteins—CTNNB1—kidney cancer	0.000241	0.00115	CbGpPWpGaD
Tranexamic Acid—Asthenia—Doxorubicin—kidney cancer	0.000239	0.000358	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—KRAS—kidney cancer	0.00023	0.00109	CbGpPWpGaD
Tranexamic Acid—Diarrhoea—Doxorubicin—kidney cancer	0.000228	0.000342	CcSEcCtD
Tranexamic Acid—Dizziness—Doxorubicin—kidney cancer	0.000221	0.00033	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—IGF2—kidney cancer	0.000218	0.00104	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CDKN2B—kidney cancer	0.000218	0.00103	CbGpPWpGaD
Tranexamic Acid—Vomiting—Doxorubicin—kidney cancer	0.000212	0.000318	CcSEcCtD
Tranexamic Acid—PLG—Signaling Pathways—IGF1R—kidney cancer	0.000211	0.001	CbGpPWpGaD
Tranexamic Acid—PLG—Hemostasis—PIK3CA—kidney cancer	0.000211	0.001	CbGpPWpGaD
Tranexamic Acid—Headache—Doxorubicin—kidney cancer	0.000209	0.000313	CcSEcCtD
Tranexamic Acid—PLG—Hemostasis—TP53—kidney cancer	0.000204	0.000968	CbGpPWpGaD
Tranexamic Acid—Nausea—Doxorubicin—kidney cancer	0.000198	0.000297	CcSEcCtD
Tranexamic Acid—SLC15A2—Transmembrane transport of small molecules—RAF1—kidney cancer	0.000175	0.000831	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—HIF1A—kidney cancer	0.000174	0.000825	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TSC2—kidney cancer	0.000173	0.000822	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KDR—kidney cancer	0.000166	0.000789	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—APC—kidney cancer	0.000153	0.000726	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KIT—kidney cancer	0.000153	0.000726	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—POMC—kidney cancer	0.000146	0.000691	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—BRAF—kidney cancer	0.000144	0.000683	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—RAF1—kidney cancer	0.00012	0.00057	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—RELA—kidney cancer	0.00012	0.000568	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—ERBB2—kidney cancer	0.000119	0.000564	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MTOR—kidney cancer	0.000117	0.000557	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CDKN1B—kidney cancer	0.00011	0.000522	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—IL2—kidney cancer	0.000108	0.000511	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CCND1—kidney cancer	0.000105	0.000498	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—JUN—kidney cancer	0.000105	0.000497	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—CTNNB1—kidney cancer	0.000104	0.000493	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PTEN—kidney cancer	0.000101	0.000481	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—VEGFA—kidney cancer	9.16e-05	0.000434	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MAPK3—kidney cancer	8.67e-05	0.000411	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MYC—kidney cancer	8.43e-05	0.0004	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—MAPK1—kidney cancer	8.25e-05	0.000391	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—KRAS—kidney cancer	7.79e-05	0.000369	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—PIK3CA—kidney cancer	7.16e-05	0.000339	CbGpPWpGaD
Tranexamic Acid—PLG—Signaling Pathways—TP53—kidney cancer	6.92e-05	0.000328	CbGpPWpGaD
